EMAIL THIS PAGE TO A FRIEND

Disease models & mechanisms

Heterozygous disruption of activin receptor-like kinase 1 is associated with increased arterial pressure in mice.


PMID 26398936

Abstract

The activin receptor-like kinase 1 (ALK-1) is a type I cell-surface receptor for the transforming growth factor-β (TGF-β) family of proteins. Hypertension is related to TGF-β1, because increased TGF-β1 expression is correlated with an elevation in arterial pressure (AP) and TGF-β expression is upregulated by the renin-angiotensin-aldosterone system. The purpose of this study was to assess the role of ALK-1 in regulation of AP using Alk1 haploinsufficient mice (Alk1(+/-)). We observed that systolic and diastolic AP were significantly higher in Alk1(+/-) than in Alk1(+/+) mice, and all functional and structural cardiac parameters (echocardiography and electrocardiography) were similar in both groups. Alk1(+/-) mice showed alterations in the circadian rhythm of AP, with higher AP than Alk1(+/+) mice during most of the light period. Higher AP in Alk1(+/-) mice is not a result of a reduction in the NO-dependent vasodilator response or of overactivation of the peripheral renin-angiotensin system. However, intracerebroventricular administration of losartan had a hypotensive effect in Alk1(+/-) and not in Alk1(+/+) mice. Alk1(+/-) mice showed a greater hypotensive response to the β-adrenergic antagonist atenolol and higher concentrations of epinephrine and norepinephrine in plasma than Alk1(+/+) mice. The number of brain cholinergic neurons in the anterior basal forebrain was reduced in Alk1(+/-) mice. Thus, we concluded that the ALK-1 receptor is involved in the control of AP, and the high AP of Alk1(+/-) mice is explained mainly by the sympathetic overactivation shown by these animals, which is probably related to the decreased number of cholinergic neurons.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

L6914
L-Leucine, PharmaGrade, Ajinomoto, EP, JP, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture
C6H13NO2
L8912
L-Leucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
C6H13NO2
L8000
L-Leucine, reagent grade, ≥98% (HPLC)
C6H13NO2
61819
L-Leucine, BioUltra, ≥99.5% (NT)
C6H13NO2
W329703
L-Leucine, 99%, FG
C6H13NO2
222488
N-(1-Naphthyl)ethylenediamine dihydrochloride, ACS reagent, >98%
C12H14N2 · 2HCl
N9125
N-(1-Naphthyl)ethylenediamine dihydrochloride, ≥98%
C12H14N2 · 2HCl
345245
Phosphoric acid, 85 wt. % in H2O, 99.99% trace metals basis
H3O4P
452289
Phosphoric acid, ≥85 wt. % in H2O, ≥99.999% trace metals basis
H3O4P
466123
Phosphoric acid, crystalline, ≥99.999% trace metals basis
H3O4P
79617
Phosphoric acid, BioUltra, ≥85% (T)
H3O4P
P5811
Phosphoric acid, BioReagent, suitable for insect cell culture, 85%
H3O4P
W290017
Phosphoric acid solution, 85 wt. % in H2O, FCC, FG
H3O4P
612162
Phosphoric acid solution, NMR reference standard, 85% in D2O (99.9 atom % D), NMR tube size 4.2 mm × 8 in. , WGS-5BL Coaxial NMR tube
H3O4P
698822
Phosphoric acid solution, NMR reference standard, 85% in D2O (99.9 atom % D), NMR tube size 5 mm × 8 in.
H3O4P
699608
Phosphoric acid solution, NMR reference standard, 85% in D2O (99.9 atom % D), NMR tube size 3 mm × 8 in.
H3O4P
S9251
Sulfanilamide, ≥98%
C6H8N2O2S
33626
Sulfanilamide, puriss. p.a., ≥99% (calc. to the dried substance)
C6H8N2O2S